A PHASE 1, OPEN-LABEL, FIXED SEQUENCE, 2-PERIOD STUDY IN HEALTHY ADULT MALE PARTICIPANTS TO ASSESS THE MASS BALANCE, ABSOLUTE BIOAVAILABILITY, FRACTION ABSORBED, AND PHARMACOKINETICS OF [14C]PF-06882961
Latest Information Update: 27 Nov 2020
At a glance
- Drugs Danuglipron (Primary) ; Danuglipron (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 23 Nov 2020 Status changed from recruiting to completed.
- 07 Aug 2020 New trial record
- 06 Aug 2020 Status changed from not yet recruiting to recruiting.